Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,479 across all filing types
Latest filing 2022-01-25 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing Classification · 1% confidence The document is a formal announcement from Coloplast A/S detailing the allocation of stock options to several members of senior management (President & CEO, CFO, EVPs). This type of disclosure, which involves transactions by directors/executives concerning company securities (even if options are allocated at zero price), falls under insider trading or executive transaction reporting requirements, often mandated by regulations like MAR (Market Abuse Regulation, referenced by 'Markedsmisbrugsforordningen art. 19'). Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate category for reporting personal share/option transactions by directors and executives. Although it is an allocation rather than a direct purchase/sale, it is a report of insider activity.
2022-01-25 Danish
Coloplast A/S - Allocation of Share Options
Director's Dealing Classification · 1% confidence The document is a formal notification of transactions involving company shares and stock options by members of the executive management team (CEO, CFO, and other EVPs). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which mandates the disclosure of transactions by persons discharging managerial responsibilities. This falls directly under the category of Director's Dealing (insider trades).
2022-01-25 Danish
Coloplast A/S - Allocation of Share Options
Director's Dealing Classification · 1% confidence The document is a formal notification of share option allocations to company executives (Kristian Villumsen, Anders Lonning-Skovgaard, etc.). It explicitly references the 'Market Abuse Regulation article 19' regarding transactions of executives and related parties. This is a standard disclosure for insider dealings or director-related transactions, which falls under the 'Director's Dealing' category.
2022-01-25 English
Director's Dealing 2021
Director's Dealing Classification · 1% confidence The document title translates to "Coloplast A/S - Trading in Coloplast shares by members of the Board of Directors, executive management, or closely related persons." This directly relates to insider trading or director dealings. The text is very short (614 characters) and explicitly states, "Se venligst vedlagte pdf" (Please see the attached pdf) and provides a link to a file named 'handel_med_aktier' (trading in shares). According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement pointing to an attached document should be classified as a Report Publication Announcement (RPA) or the most specific category if available. Since the content is explicitly about director/insider trading, the most specific category is 'Director's Dealing' (DIRS). However, the document itself is merely an announcement pointing to the actual filing (the PDF). Given the structure (short announcement pointing to an attachment), RPA is a strong candidate, but DIRS describes the *subject matter* of the attached document. Since the prompt asks to classify the *document text provided*, and this text is a notification that the director dealing information is attached, RPA is technically correct based on the length/structure rule. Let's re-evaluate the definitions: DIRS is for the 'Report of personal share transactions by company directors and executives (insider trades)'. RPA is for 'Announcement regarding the timing, release, or publication of company reports'. Because the subject matter is so specific (Director's Dealing), and this announcement is the standard way such information is disseminated before the full report is read, DIRS is the intended classification for the *topic*, but RPA fits the *format* (short announcement of a report). In many regulatory contexts, the announcement of a DIRS filing is classified under DIRS itself if the subject is clear. Given the strong subject matter match to DIRS, I will prioritize the subject matter over the strict 'announcement' rule, as the announcement *is* the DIRS filing notification. If DIRS is interpreted as the actual report, and RPA as the announcement, the short length favors RPA. However, DIRS is a very specific category for this exact content type. I will classify it as DIRS because the content is unambiguously about director dealings, and the announcement itself serves as the official notification of that event.
2021-12-16 Danish
Director's Dealing 2021
Director's Dealing Classification · 1% confidence The document title explicitly states 'Trading in Coloplast shares by board members, executives or associated persons'. This directly corresponds to the definition of Director's Dealing (insider trades). Although the text is very short and points to an attachment, the specific subject matter overrides the general 'Report Publication Announcement' rule, as the core content is about insider transactions, which has its own dedicated code (DIRS).
2021-12-16 English
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of a transaction in company shares by a person closely associated with a member of the board (Gerda Louis-Hansen, related to the Vice Chairman). It explicitly cites the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which governs the reporting of insider dealings. The document provides detailed tables of the transaction dates, prices, and volumes, which is the standard format for a Director's Dealing (or Person Closely Associated) disclosure.
2021-12-16 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.